Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
about
The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007)Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasisA comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administrationProgress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial diseaseWhat Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration ProgramsThe effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challengesProspects for the control of neglected tropical diseases by mass drug administration.Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages.Molecular xenomonitoring (MX) and transmission assessment survey (TAS) of lymphatic filariasis elimination in two villages, Menoufyia Governorate, Egypt.Changes in cytokine, filarial antigen, and DNA levels associated with adverse events following treatment of lymphatic filariasis.
P2860
Q28474146-A5B0DDDF-2B9C-4FAF-A6B2-87FA1370005CQ28484840-FE5C9789-665D-4BA3-B0E8-B3E8DC293733Q28544914-9D3305A0-885B-4302-9BBE-0E9821D11432Q28545108-5F9A8DAB-DD43-464F-9ACE-76F6599E20CDQ28550175-F99055C8-6B8E-48C0-8BDF-7B045CBB8ABAQ36377501-DB078820-6670-41DE-BE7F-31602387B957Q36509658-B5A52D7D-8739-413C-95FB-B23E8ED44E6FQ37288857-1757F08D-9335-4255-BD70-D301C07FD60EQ37557676-5D3BBC08-B994-48DB-AE8D-8C089556B0DDQ37685563-BF3CB91D-8DE1-4C14-993F-58FB51CE894FQ37834370-C98F5E6E-7051-4FF9-8F8B-0D89AD85F72EQ39014924-6C6B63CA-580D-446C-B6D1-833749849B80Q43943647-CFDBE52B-33FA-486B-BFE5-E727EAD2A041Q44163504-2896E3E5-4832-4E19-86C7-B847E7A86915Q46522848-2BAE429A-1B96-4E1A-BCF9-9B2309FEEFF8
P2860
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Advances and challenges in pre ...... mmes by mathematical modelling
@ast
Advances and challenges in pre ...... mmes by mathematical modelling
@en
Advances and challenges in pre ...... mmes by mathematical modelling
@nl
type
label
Advances and challenges in pre ...... mmes by mathematical modelling
@ast
Advances and challenges in pre ...... mmes by mathematical modelling
@en
Advances and challenges in pre ...... mmes by mathematical modelling
@nl
prefLabel
Advances and challenges in pre ...... mmes by mathematical modelling
@ast
Advances and challenges in pre ...... mmes by mathematical modelling
@en
Advances and challenges in pre ...... mmes by mathematical modelling
@nl
P2093
P2860
P356
P1433
P1476
Advances and challenges in pre ...... mmes by mathematical modelling
@en
P2093
J Dik F Habbema
Sake J de Vlas
Wilma A Stolk
P2860
P2888
P356
10.1186/1475-2883-5-5
P577
2006-03-28T00:00:00Z
P5875
P6179
1034830313